BR112015005363A2 - polytetrafluoroethylene copolymer emulsions - Google Patents

polytetrafluoroethylene copolymer emulsions

Info

Publication number
BR112015005363A2
BR112015005363A2 BR112015005363A BR112015005363A BR112015005363A2 BR 112015005363 A2 BR112015005363 A2 BR 112015005363A2 BR 112015005363 A BR112015005363 A BR 112015005363A BR 112015005363 A BR112015005363 A BR 112015005363A BR 112015005363 A2 BR112015005363 A2 BR 112015005363A2
Authority
BR
Brazil
Prior art keywords
solvents
dissolved
copolymer emulsions
polytetrafluoroethylene copolymer
copolymers
Prior art date
Application number
BR112015005363A
Other languages
Portuguese (pt)
Inventor
H Cully Edward
D Drumheller Paul
L Cleek Robert
A Holland Theresa
Original Assignee
Gore & Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gore & Ass filed Critical Gore & Ass
Publication of BR112015005363A2 publication Critical patent/BR112015005363A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/14—Post-treatment to improve physical properties
    • A61L17/145—Coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D131/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid, or of a haloformic acid; Coating compositions based on derivatives of such polymers
    • C09D131/02—Homopolymers or copolymers of esters of monocarboxylic acids
    • C09D131/04—Homopolymers or copolymers of vinyl acetate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/02—Methods for coating medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/04—Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/06—Coatings containing a mixture of two or more compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

resumo “emulsões de copolímero de politetrafluoretileno” a presente descrição é direcionada a uma classe de copolímeros fluorados, tais como copolímeros de ptfe, que podem ser dissolvidos em solventes de baixa toxicidade, tais como solventes de classe iii, e que permitem a criação de emulsões água-em-solvente estáveis compreendendo os copolímeros fluorados dissolvidos em solventes de baixa toxicidade e um agente hidrofílico (por exemplo, um agente terapêutico), dissolvido em um solvente aquoso, tal como água ou solução salina.abstract “polytetrafluoroethylene copolymer emulsions” the present description is directed to a class of fluorinated copolymers, such as ptfe copolymers, which can be dissolved in low toxicity solvents, such as class III solvents, and which allow the creation of emulsions stable water-in-solvents comprising the fluorinated copolymers dissolved in low-toxic solvents and a hydrophilic agent (e.g., a therapeutic agent) dissolved in an aqueous solvent, such as water or saline.

BR112015005363A 2012-09-13 2013-09-13 polytetrafluoroethylene copolymer emulsions BR112015005363A2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261700842P 2012-09-13 2012-09-13
US201361780913P 2013-03-13 2013-03-13
US14/025,706 US9731017B2 (en) 2012-09-13 2013-09-12 Polytetrafluoroethylene co-polymer emulsions
US14/025,708 US10092653B2 (en) 2012-09-13 2013-09-12 Polytetrafluoroethylene co-polymer emulsions
PCT/US2013/059787 WO2014043556A2 (en) 2012-09-13 2013-09-13 Polytetrafluoroethylene co-polymer emulsions

Publications (1)

Publication Number Publication Date
BR112015005363A2 true BR112015005363A2 (en) 2017-07-04

Family

ID=50233483

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015005363A BR112015005363A2 (en) 2012-09-13 2013-09-13 polytetrafluoroethylene copolymer emulsions

Country Status (12)

Country Link
US (5) US10092653B2 (en)
EP (1) EP2895210B1 (en)
JP (3) JP6254596B2 (en)
KR (1) KR102300478B1 (en)
CN (2) CN109771696B (en)
AU (1) AU2013315142B2 (en)
BR (1) BR112015005363A2 (en)
CA (1) CA2882768C (en)
ES (1) ES2788327T3 (en)
HK (1) HK1206286A1 (en)
RU (1) RU2015113410A (en)
WO (1) WO2014043556A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10369327B2 (en) * 2010-04-28 2019-08-06 Clph, Llc Catheters with lubricious linings and methods for making and using them
US10092653B2 (en) * 2012-09-13 2018-10-09 W. L. Gore & Associates, Inc. Polytetrafluoroethylene co-polymer emulsions
CN107250179B (en) * 2015-02-20 2021-01-05 大金工业株式会社 Hydrophilizing agent, composition containing hydrophilizing agent, and porous polymer membrane
EP3286245A4 (en) * 2015-04-21 2018-09-19 Ran Biotechnologies, Inc. Novel fluorinated surfactants
CN111295094A (en) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 Freeze-drying container and method for using freeze-drying container
JP2022525742A (en) 2019-03-14 2022-05-19 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー Freeze-drying loading tray assembly and system
CN114728096A (en) * 2019-11-13 2022-07-08 W.L.戈尔及同仁股份有限公司 Liquid composition and porous hardened material containing copolymer having tetrafluoroethylene and vinyl moiety
CN115135306A (en) 2020-01-24 2022-09-30 W.L.戈尔及同仁股份有限公司 Slow-release matrix for adventitial or periadventitial nerve ablation and application thereof
CN112986216B (en) * 2021-05-06 2021-07-30 江西省药品检验检测研究院 Method for detecting typical chemical components of skin-care traditional Chinese medicine product by surface enhanced Raman spectroscopy
WO2023201067A2 (en) 2022-04-14 2023-10-19 W. L. Gore & Associates, Inc. Chemical entities

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4300565A (en) 1977-05-23 1981-11-17 American Cyanamid Company Synthetic polyester surgical articles
US4243775A (en) 1978-11-13 1981-01-06 American Cyanamid Company Synthetic polyester surgical articles
SE8200751L (en) 1982-02-09 1983-08-10 Olle Larm PROCEDURE FOR COVALENT COUPLING FOR MANUFACTURE OF CONJUGATE AND REQUIRED PRODUCTS
JPH02502832A (en) 1987-11-20 1990-09-06 アライド‐シグナル・インコーポレーテッド Fluorinated copolymer, film thereof, and method for producing the copolymer
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5080665A (en) 1990-07-06 1992-01-14 American Cyanamid Company Deformable, absorbable surgical device
US5188890A (en) * 1991-03-15 1993-02-23 Japan Gore-Tex, Inc. Metallized porous flourinated resin and process therefor
JPH05261256A (en) * 1992-03-19 1993-10-12 Japan Gore Tex Inc Fluorine-containing copolymer film and separating membrane
US5559621A (en) 1993-07-22 1996-09-24 Toppan Printing Co., Ltd. Liquid crystal having a plurality of rectilinear barrier members
GB2282328B (en) 1993-09-29 1997-10-08 Johnson & Johnson Medical Absorbable structures for ligament and tendon repair
US5413863A (en) * 1993-11-04 1995-05-09 E. I. Du Pont De Nemours And Company Recording medium with inproved adhesion to glass
US5502092A (en) 1994-02-18 1996-03-26 Minnesota Mining And Manufacturing Company Biocompatible porous matrix of bioabsorbable material
EP0823146B1 (en) 1996-02-23 2001-10-24 Koninklijke Philips Electronics N.V. Reduced complexity signal converter
US20040024448A1 (en) * 2002-08-05 2004-02-05 Chang James W. Thermoplastic fluoropolymer-coated medical devices
US20040063805A1 (en) 2002-09-19 2004-04-01 Pacetti Stephen D. Coatings for implantable medical devices and methods for fabrication thereof
US9114198B2 (en) 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
FR2877846B1 (en) * 2004-11-15 2008-12-05 Univ Lille Sciences Tech BIOMATERIAL CARRIERS OF CYCLODEXTRINS WITH IMPROVED ABSORPTION PROPERTIES AND PROGRESSIVE AND DELAYED RELEASE OF THERAPEUTIC MOLECULES
US7655584B2 (en) 2005-07-29 2010-02-02 Gore Enterprise Holdings, Inc. Highly porous self-cohered web materials
US20090053391A1 (en) 2005-12-06 2009-02-26 Ludwig Florian N Method Of Coating A Drug-Releasing Layer Onto A Substrate
JP4447550B2 (en) * 2005-12-12 2010-04-07 株式会社トクヤマ Separation material for conformance test
US8062282B2 (en) * 2006-02-13 2011-11-22 Fossa Medical, Inc. Methods and apparatus for temporarily occluding body openings
KR100916750B1 (en) * 2007-10-12 2009-09-14 (주) 태웅메디칼 Coating agent for drug releasing stent, manufacturing method thereof and drug releasing stent coated with the coating agent
US8637144B2 (en) 2007-10-04 2014-01-28 W. L. Gore & Associates, Inc. Expandable TFE copolymers, method of making, and porous, expended articles thereof
EP2207854B1 (en) 2007-10-26 2012-01-25 Basf Se Security element
EP2249893A2 (en) 2008-02-01 2010-11-17 Boston Scientific Scimed, Inc. Drug-coated medical devices for differential drug release
CN101977619B (en) 2008-02-15 2013-06-05 诺沃百欧公司 Soluble complexes of curcumin
CN101353502B (en) * 2008-09-11 2010-08-04 哈尔滨工程大学 Polytetrafluorethylene coating material for medical apparatus surface and coating method thereof
US8048442B1 (en) 2008-09-16 2011-11-01 Abbott Cardiovascular Systems Inc. Modified heparin-based coatings and related drug eluting stents
US8996134B2 (en) * 2008-11-07 2015-03-31 W. L. Gore & Associates, Inc. Implantable lead
CN101474160A (en) * 2009-01-08 2009-07-08 上海交通大学 Oil in oil-oil in oil-water in oil method for preparing microballoons
SG178577A1 (en) 2009-08-26 2012-04-27 Otsuka Medical Devices Co Ltd Medical device for placement into a lumen and manufacturing method thereof
US8591932B2 (en) 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
US20110098797A1 (en) * 2009-10-23 2011-04-28 Cleek Robert L Drug eluting composite
US10092653B2 (en) * 2012-09-13 2018-10-09 W. L. Gore & Associates, Inc. Polytetrafluoroethylene co-polymer emulsions

Also Published As

Publication number Publication date
WO2014043556A3 (en) 2014-05-08
US10688188B2 (en) 2020-06-23
CN109771696B (en) 2022-04-22
US20190000979A1 (en) 2019-01-03
KR20150054845A (en) 2015-05-20
CN104797275A (en) 2015-07-22
JP2018070630A (en) 2018-05-10
ES2788327T3 (en) 2020-10-21
RU2015113410A (en) 2016-11-10
CN104797275B (en) 2019-03-19
JP2015528381A (en) 2015-09-28
CA2882768C (en) 2018-04-24
EP2895210B1 (en) 2020-02-12
HK1206286A1 (en) 2016-01-08
CA2882768A1 (en) 2014-03-20
US20230285565A1 (en) 2023-09-14
EP2895210A2 (en) 2015-07-22
US20140072514A1 (en) 2014-03-13
AU2013315142A1 (en) 2015-03-12
WO2014043556A2 (en) 2014-03-20
JP6626076B2 (en) 2019-12-25
US20190224323A1 (en) 2019-07-25
US9731017B2 (en) 2017-08-15
JP6898387B2 (en) 2021-07-07
JP2019189634A (en) 2019-10-31
US10092653B2 (en) 2018-10-09
AU2013315142B2 (en) 2016-06-02
US20140072518A1 (en) 2014-03-13
JP6254596B2 (en) 2017-12-27
US11642412B2 (en) 2023-05-09
CN109771696A (en) 2019-05-21
KR102300478B1 (en) 2021-09-10

Similar Documents

Publication Publication Date Title
BR112015005363A2 (en) polytetrafluoroethylene copolymer emulsions
CL2017000240A1 (en) Active compounds towards bromodominiums
CL2017001488A1 (en) Benzamides substituted with 1,3-thiazol-2-yl
CO7240372A2 (en) Topical non-aqueous pharmaceutical formulations
EA201600139A1 (en) INJECTION DEVICE WITH MINIMUM CAPTURE AND ITS USE
BR112015028152A2 (en) acc inhibitors and uses thereof
BR112017013691A2 (en) composition comprising a multistage polymer, its method of preparation and its use
CO7190239A2 (en) Polymer based dialysate
SV2016005265A (en) PROCESS TO PRODUCE A STABLE LOW CONCENTRATION NORADRENALINE INJECTABLE SOLUTION
BR112019008230A2 (en) hydrogen sulfide release polymer compounds
BR112017006113A2 (en) synergistic combinations of auristatin
BR112017004798A2 (en) pharmaceutical composition containing a hydroxamic acid derivative or a salt thereof
BR112015014787A2 (en) corrosion and fouling mitigation using non-phosphorus-based additives
DOP2016000170A (en) COMPOUNDS DERIVED FROM HYDROXIFORMAMIDE AND USES OF THE SAME
BR112016015394A8 (en) electric pulse generation systems
BR112016003356A8 (en) composition for improving the health of the respiratory system and increasing the concentration of hypochiocyanate ions in vertebrate lungs and their use
UY34420A (en) ? METHODS OF TREATMENT OF THE HEPATITIS C VIRUS WITH WHICH OF GS-7977 AND RIBAVIRINE, COMPOSITIONS AND USES "
BR112017000849A2 (en) nonstick composition
BR112015012778A2 (en) exhaust component support structure
AR105098A1 (en) HIGHLY EFFECTIVE HEMOSTATIC ADHESIVE POLYMER SUPPORT
CO2018000768A2 (en) Intravenous administration of citrulline during surgery
BR112018069079A2 (en) live attenuated alphavirus constructs and methods and uses thereof
EA201891033A1 (en) COMPOSITION WITH FAVORABLE EFFECT ON SKIN BASED ON SOLVENT CONTAINING HYDROXY GROUP
UY35390A (en) COMPOUNDS WITH ANTI-HCV ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
BR112015031901A2 (en) compositions and methods for postharvest treatment

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]